First slide

To expand mobile cardiac health portfolio, Boston Scientific announced to acquire Preventice Solutions, Inc for an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.

  • Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors – including short and long-term Holter monitors – to cardiac event monitors and mobile cardiac telemetry.
  • The Preventice product portfolio includes the BodyGuardian family of remote, wearable cardiac monitors for adult and pediatric patients.
  • The monitors use a fully-integrated, cloud-based platform supported by an independent diagnostic testing facility, where clinical technicians and artificial intelligence (AI) algorithms provide insights that may lead to improved clinical diagnoses and outcomes.

    In Nov 2020, Boston Scientific Corporation has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, a European specialty pharmaceutical group, to sell its BTG Specialty Pharmaceuticals business for $800 million.

    In June 2020, Boston Scientific Corporation has announced completion of its acquisition of a privately-held company Vertiflex, Inc., that developed and commercialized the Superion® Indirect Decompression System.

    In April 2020, Boston Scientific Corporation announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.

    In April 2020, Boston Scientific Corporation has signed a virtual power purchase agreement (VPPA) that represents the largest step the company has taken to achieve its goal of global carbon neutral manufacturing and distribution by 2030. The agreement, with Clearway Energy Group, will address the electricity load for the company’s U.S. operations, which represents 45 percent of the company’s total carbon footprint.

About Boston Scientific
Boston Scientific, headquartered in Marlborough, Massachusetts, United States, is global innovative medical solution provider. The company is a leading manufacturer of medical device to improve the health of patients around the world. The company provides healthcare services and medical products in more than 100 countries and it has approximately 29,000 employees across the globe.

Prominent Global Investors

View all

Related News